Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...

A new highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...

Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in ...

"Population-scale spatial has arrived and is on center-stage at AGBT 2026," stated Christopher Mason, PhD, Professor of Physiology and Biophysics at Weill Cornell Medicine. " [Jiwoon Park] is ...

As of Wednesday, February 25, CytomX Therapeutics, Inc.’s CTMX share price has surged by 7.44%, which has investors questioning if this is right time to sell.

Lung cancer cells are able to take advantage of a person’s immune system, specifically T cells, to protect the tumor, according to new research recently published in Cancer Immunology Research.

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech ...

‘Wnt signaling’ — a pathway essential for stem cell maintenance and tissue regeneration — is often activated in gastric cancer through external ligand stimulation rather than genetic mutation. This ...

Additional intellectual property protection reinforces the strategic value of IP-001 and supports ongoing clinical ...

The central question is no longer whether we can innovate, but whether innovation can truly reach patients in time.

Priya Hays, Hays Documentation Specialists, LLC, discusses biomarker discovery through artificial intelligence and ...